Using_a_bacteriophage_that_targets_Klebsiella_pneumoniae_to_elucidate_regulatory_mechanisms_of_the_LPS_and_its_range_of_potential_modifications-sc-4932
Using_a_bacteriophage_that_targets_Klebsiella_pneumoniae_to_elucidate_regulatory_mechanisms_of_the_LPS_and_its_range_of_potential_modifications
Using a bacteriophage that targets Klebsiella pneumoniae to elucidate regulatory mechanisms of the LPS and its range of potential modifications  1) This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute please see http://www.sanger.ac.uk/datasharing/
With the emergence of multiple drug resistant Klebsiella, mechanisms for understanding more comprehensively its pathogenicity are being actively investigated by various methodologies. One such tool is the use of bacteriophage and potentially TraDIS in combination. These will allow us to elucidate the various regulatory control systems and potential unknown factors such as sRNA that play a role in LPS, Capsule or modification enzymes of LPS during growth in a variety of environmental or host conditions.